Analysis of Exportins Expression Unveils Their Prognostic Significance in Colon Adenocarcinoma: Insights from Public Databases

Overview

Journal Discov Oncol

Publisher Springer

Specialty Oncology

Date 2025 Jan 8

PMID 39776001

Authors

Punita Kalia

Rohini Ravindran Nair

Suresh Singh Yadav

Affiliations

Soon will be listed here.

Abstract

Colon cancer remains a significant health burden globally, necessitating deeper investigation. Identification and targeting of prognostic markers can significantly improve the current therapeutic approaches for colon cancer. The differential nuclear transport (import and export) of cellular proteins, plays an important role in tumor progression. Exportins, critical mediators of nuclear export, have emerged as potential players in cancer pathogenesis. However, their precise roles and prognostic significance in colon adenocarcinoma remain elusive. This study was designed to comprehensively analyse the expression and prognostic significance of all seven exportins in Colon Adenocarcinoma (COAD) using the online public database. We used public databases UALCAN, C-Bio portal, Human Protein Atlas (HPA), and DAVID, to investigate exportins in COAD patients. Kaplan-Meier plotter, Gene ontology (GO), TIMER, STRING, and KEGG were used to analyse data and draw conclusions. Our observations showed a significant correlation of exportins expression with clinical parameters, used to predict a patient's prognosis in general, such as advancing tumor stage, overall/relapse-free survival, and immune cell infiltrations. Mutation analysis showed the presence of amplifications, missense mutations in XPO2 and XPO4, and deep deletions in XPO7 genes contributing to disease progression and patients survival. This study highlights the potential use of exportins as novel prognostic biomarkers and therapeutic targets for colon adenocarcinoma progression and management.

References

Mutka S, Yang W, Dong S, Ward S, Craig D, Timmermans P . Identification of nuclear export inhibitors with potent anticancer activity in vivo. Cancer Res. 2009; 69(2):510-7. PMC: 2635062. DOI: 10.1158/0008-5472.CAN-08-0858. View

Kudo N, Wolff B, Sekimoto T, Schreiner E, Yoneda Y, Yanagida M . Leptomycin B inhibition of signal-mediated nuclear export by direct binding to CRM1. Exp Cell Res. 1998; 242(2):540-7. DOI: 10.1006/excr.1998.4136. View

Li T, Fu J, Zeng Z, Cohen D, Li J, Chen Q . TIMER2.0 for analysis of tumor-infiltrating immune cells. Nucleic Acids Res. 2020; 48(W1):W509-W514. PMC: 7319575. DOI: 10.1093/nar/gkaa407. View

Gu X, Gao X, Li X, Qi X, Ma M, Qin S . Prognostic significance of neutrophil-to-lymphocyte ratio in prostate cancer: evidence from 16,266 patients. Sci Rep. 2016; 6:22089. PMC: 4766531. DOI: 10.1038/srep22089. View

Lei J, Luo J, Liu Q, Wang X . Identifying cancer subtypes based on embryonic and hematopoietic stem cell signatures in pan-cancer. Cell Oncol (Dordr). 2023; 47(2):587-605. DOI: 10.1007/s13402-023-00886-7. View

Shigeyasu K, Okugawa Y, Toden S, Boland C, Goel A . Exportin-5 Functions as an Oncogene and a Potential Therapeutic Target in Colorectal Cancer. Clin Cancer Res. 2016; 23(5):1312-1322. PMC: 5435115. DOI: 10.1158/1078-0432.CCR-16-1023. View

Kirli K, Karaca S, Dehne H, Samwer M, Pan K, Lenz C . A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning. Elife. 2015; 4. PMC: 4764573. DOI: 10.7554/eLife.11466. View

Azmi A, Uddin M, Mohammad R . Author Correction: The nuclear export protein XPO1 - from biology to targeted therapy. Nat Rev Clin Oncol. 2020; 18(3):190. DOI: 10.1038/s41571-020-00454-0. View

Liu B, Liu X, Wang G, Chen Y . The immune cell infiltration-associated molecular subtypes and gene signature predict prognosis for osteosarcoma patients. Sci Rep. 2024; 14(1):5184. PMC: 10908810. DOI: 10.1038/s41598-024-55890-0. View

Tunccan T, Kilic C, Duran A, Ozlugedik S, Ant A, Alkan G . Role of CSE1L expression in determining recurrence and survival of laryngeal tumors. Eur Arch Otorhinolaryngol. 2022; 279(7):3639-3644. DOI: 10.1007/s00405-021-07206-5. View

10.

Khan M, Khan Z, Uddin Y, Mustafa S, Shaukat I, Pan J . Evaluating the Oncogenic and Tumor Suppressor Role of XPO5 in Different Tissue Tumor Types. Asian Pac J Cancer Prev. 2018; 19(4):1119-1125. PMC: 6031805. DOI: 10.22034/APJCP.2018.19.4.1119. View

11.

Kodiha M, Tran D, Morogan A, Qian C, Stochaj U . Dissecting the signaling events that impact classical nuclear import and target nuclear transport factors. PLoS One. 2009; 4(12):e8420. PMC: 2793512. DOI: 10.1371/journal.pone.0008420. View

12.

Zhou Z, Mo S, Dai W, Xiang W, Han L, Li Q . Prognostic nomograms for predicting cause-specific survival and overall survival of stage I-III colon cancer patients: a large population-based study. Cancer Cell Int. 2020; 19:355. PMC: 6935115. DOI: 10.1186/s12935-019-1079-4. View

12.

Wang D, Liufu J, Yang Q, Dai S, Wang J, Xie B . Identification and validation of a novel signature as a diagnostic and prognostic biomarker in colorectal cancer. Biol Direct. 2022; 17(1):29. PMC: 9628086. DOI: 10.1186/s13062-022-00342-w. View

13.

Liu L, Wang J, Xu H, Zhao S, Wang L, Huang J . Prognosis influence of additional chromosome abnormalities in newly diagnosed acute promyelocytic leukemia with t(15;17)(q24;q21). Hematology. 2023; 29(1):2293513. DOI: 10.1080/16078454.2023.2293513. View

13.

Yuksel U, Dilek G, Dogan L, Gulcelik M, Berberoglu U . The relationship between CSE1L expression and axillary lymph node metastasis in breast cancer. Tumori. 2015; 101(2):194-8. DOI: 10.5301/tj.5000239. View

14.

Seervi M, Sumi S, Chandrasekharan A, Sharma A, Santhoshkumar T . Molecular profiling of anastatic cancer cells: potential role of the nuclear export pathway. Cell Oncol (Dordr). 2019; 42(5):645-661. DOI: 10.1007/s13402-019-00451-1. View

15.

Sherman B, Hao M, Qiu J, Jiao X, Baseler M, Lane H . DAVID: a web server for functional enrichment analysis and functional annotation of gene lists (2021 update). Nucleic Acids Res. 2022; 50(W1):W216-W221. PMC: 9252805. DOI: 10.1093/nar/gkac194. View

16.

Wang H, Teng X, Lin Y, Jiang C, Chen X, Zhang Y . Targeting XPO6 inhibits prostate cancer progression and enhances the suppressive efficacy of docetaxel. Discov Oncol. 2023; 14(1):82. PMC: 10224898. DOI: 10.1007/s12672-023-00700-8. View

17.

Chen L, Huang Y, Zhou L, Lian Y, Wang J, Chen D . Prognostic roles of the transcriptional expression of exportins in hepatocellular carcinoma. Biosci Rep. 2019; 39(8). PMC: 6702357. DOI: 10.1042/BSR20190827. View